Novo Nordisk A/S (NYSE:NVO)

Thursday’s Trading Day
44.40 +0.82 / +1.88%
Data as of Dec 18
Day’s Change
Friday’s Pre-Market   Switch to standard view »
43.98 -0.42 / -0.95%
Volume: 54.4K
Health Technology
Pharmaceuticals: Major

Company Description

Novo Nordisk AS is engaged in the development, manufacture, and marketing of pharmaceutical products. It operates through the Diabetes Care and Biopharmaceuticals segments. The Diabetes Care segment deals with the research, development, manufacture, and marketing of products within the areas of insulin, glucagon-like-peptide 1 and related delivery systems, oral anti-diabetic products, and obesity. The Biopharmaceuticals segment handles the research, development, manufacture, and distribution of products within the areas of haemophilia, growth hormone, hormone replacement, inflammation and other therapy areas. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Contact Information

Novo Nordisk A/S
Novo All
Bagsvrd -- 2880
P:(454) 444-8888
Investor Relations:
(454) 442-4303



Other institutional6.67%
Mutual fund holders2.54%
Individual stakeholders--

Top Executives

Lars Rebien SørensenChief Executive Officer
Kåre SchultzPresident & Chief Operating Officer
Jesper BrandgaardChief Financial Officer & Executive Vice President
Lars Fruergaard JørgensenChief Information Officer & Executive VP
Mads Krogsgaard ThomsenChief Science Officer & Executive Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.